have shown that ESRP1 affects tumor progression in ER+ breast cancer cells by regulating genes involved in fatty acid/lipid metabolism and oxidation-reduction processes, and that high expression of ESRP1 is associated with poor prognosis in estrogen receptor-positive (ER+) breast tumors (90). The gene discussed is ESR1; the disease is breast neoplasm.